Latest News
Zipnosis has raised a USD17 million Series A financing round led by Safeguard Scientifics with participation from Ascension Ventures, a subsidiary of Ascension, along with existing investors Fairview Health Services, Hyde Park Venture Partners, Arthur Ventures, Waterline Ventures and Omphalos Ventures.
Proceeds will be used to expand Zipnosis’ sales and marketing efforts and to accelerate product development.
Zipnosis is the first virtual care solution that empowers health systems to launch their own branded virtual care service line staffed with their own clinicians – maximising the clinician’s time and ensuring clinically appropriate patient outcomes.
Zipnosis is the first virtual care solution
Leerink Capital Partners, the asset management affiliate of Leerink Partners, has appointed Dr Jared Kesselheim as a Managing Partner.
Based in Boston, Kesselheim is co-managing Leerink Capital Partners’ healthcare technology and services and digital healthcare investment initiative. He joins Todd Cozzens who recently came to Leerink Capital Partners from Sequoia Capital to lead Leerink’s healthcare growth equity effort.
Kesselheim has over seven years of investment experience in healthcare information technology, healthcare services and diagnostics. Most recently, Kesselheim was a leader of Bain Capital Venture’s healthcare practice, focusing on investments in healthcare information technology and services. Previously, Kesselheim completed a residency
Audax Private Equity (Audax) has completed the sale of Chesapeake IRB (Chesapeake) to Linden Capital Partners (Linden), a Chicago-based private equity firm.
Chesapeake is a leading technology-enabled provider of legally-mandated, institutional review board (IRB) services designed to ensure the protection and welfare of human subjects involved in clinical trials in the United States and Canada. Since Audax’ initial investment in 2012, Chesapeake has completed three acquisitions, expanding the company’s market share and geographic reach across the United States and Canada.
Geoffrey S Rehnert, Co-CEO of Audax Group, says: “Jeff Wendel and the Chesapeake team have done a tremendous job in
Investment bankers are expecting relatively modest bonuses of under GBP25,000 on average this year, while Private Equity staff think theirs will exceed GBP100,000, according to research by recruitment firm Astbury Marsden.
Astbury Marsden says that investment bankers anticipate that their bonuses will be worth an average of GBP24,461 in this year’s compensation round – equivalent to 25 per cent of salary.
Those working in Private Equity have the highest expectations of any sector of the City – predicting average bonuses of GBP104,125 – or 71 per cent of salary.
Private bankers and wealth managers are the next most
Ipes has entered into an agreement with KPMG to provide investors with certain services, including developing and marketing services to support investors throughout the lifecycle of the funds in which they invest.
As the Foreign Account Tax Compliance Act (FATCA) expands into the Common Reporting Standard (CRS), the services will continue to grow to include client due diligence (CDD), investor relations and possibly some tax information reporting.
In 2014 Ipes worked with KPMG to build a FATCA service and all FATCA entity classifications that Ipes undertakes for their clients are verified by KPMG. Previously, KPMG had worked with Ipes to
Beechbrook Capital has held the first close of its inaugural UK SME Credit Fund, with commitments of more than GBP100m. The fund will support UK small and medium-sized businesses with a turnover of between GBP10 million and GBP100 million and EBITDA of more than GBP1 million.
Among the institutional investors that have made commitments to the new fund are British Business Bank Investments Limited, the commercial arm of the British Business Bank, and the European Investment Fund. With additional investments to the fund already pledged, Beechbrook expects to hold a second close in the second quarter of 2016 with a
Monomoy Capital Partners, a private equity firm focused on deep value investing and operational improvement in the lower middle market, has acquired Construction Resources, and Builder Specialties. Terms of the transaction have not been disclosed.
The combination of the two businesses under the Construction Resources name creates a new specialty building products distributor for home builders in the Southeast. The company fabricates, distributes and installs countertops, appliances, hearth products, garage doors, glass and mirror products, flooring products, lighting products and cabinets. Construction Resources is now positioned as the largest ‘one-stop shop’ for specialty building products in the Southeastern US. The
US mid-market private equity firm Highlander Partners has soid ZREW Transformatory, its portfolio company in Central Europe, to R&S International Holding, a private equity owned Swiss producer of electrical products and systems for the power distribution and electrical infrastructure market.
ZREW complements the portfolio of the Swiss Rauscher & Stoecklin and the Czech SERW, both subsidiaries of R&S International Holding. All together they will form part of a leading European industry group.
ZREW, a Highlander Partners investment since 2012, is a nationally recognised manufacturer of medium-power transformers with a more than 50 year track-record in Poland. Over the course of
Harris Williams & Co has hired two senior professionals in its London office. Edward Arkus joins as a managing director and William Bain as a director; both are joining the firm’s Consumer Group.
In addition to hiring Arkus and Bain, Harris Williams & Co has engaged Christopher Darlington as a senior advisor to support and augment the firm’s consumer industry insight and expertise. The firm’s Consumer Group completed more than 20 transactions in 2015 and enters 2016 with a strong pipeline.
Arkus and Bain both have strong advisory backgrounds in the consumer, retail and leisure sectors with more than
Emperra has completed a Series B financing round of USD3.1 million, with Robert Bosch Venture Capital GmbH (RBVC), a corporate venture capital company of the Bosch Group, joining the existing investors Peppermint VenturePartners and Investitionsbank des Landes Brandenburg.
The funds will be used for further product development and to accelerate international growth, predominantly in the United States and Europe.
With its flagship product ESYSTA, Emperra has debuted the first ever fully integrated digital diabetes management system. In it, key innovations such as smart insulin pens (usable with all major insulin brands), wireless blood glucose meters, and CE-certified software work together
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
